These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 16160876)
1. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876 [TBL] [Abstract][Full Text] [Related]
2. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal. Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080 [TBL] [Abstract][Full Text] [Related]
3. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. West R; Baker CL; Cappelleri JC; Bushmakin AG Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743 [TBL] [Abstract][Full Text] [Related]
4. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Durcan MJ; Deener G; White J; Johnston JA; Gonzales D; Niaura R; Rigotti N; Sachs DP Clin Ther; 2002 Apr; 24(4):540-51. PubMed ID: 12017399 [TBL] [Abstract][Full Text] [Related]
5. The effect of bupropion on nicotine craving and withdrawal. Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415 [TBL] [Abstract][Full Text] [Related]
6. Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers. Kotlyar M; Drone D; Thuras P; Hatsukami DK; Brauer L; Adson DE; al'Absi M Nicotine Tob Res; 2011 Jun; 13(6):492-7. PubMed ID: 21378081 [TBL] [Abstract][Full Text] [Related]
7. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial. Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648 [TBL] [Abstract][Full Text] [Related]
8. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998 [TBL] [Abstract][Full Text] [Related]
9. Bupropion for the treatment of nicotine withdrawal and craving. Mooney ME; Sofuoglu M Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112 [TBL] [Abstract][Full Text] [Related]
10. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Tashkin D; Kanner R; Bailey W; Buist S; Anderson P; Nides M; Gonzales D; Dozier G; Patel MK; Jamerson B Lancet; 2001 May; 357(9268):1571-5. PubMed ID: 11377644 [TBL] [Abstract][Full Text] [Related]
11. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. George TP; Vessicchio JC; Sacco KA; Weinberger AH; Dudas MM; Allen TM; Creeden CL; Potenza MN; Feingold A; Jatlow PI Biol Psychiatry; 2008 Jun; 63(11):1092-6. PubMed ID: 18096137 [TBL] [Abstract][Full Text] [Related]
13. A comparison of sustained-release bupropion and placebo for smoking cessation. Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378 [TBL] [Abstract][Full Text] [Related]
14. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Shiffman S Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of bupropion in the management of smoking cessation. Jorenby D Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933 [TBL] [Abstract][Full Text] [Related]
16. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177 [TBL] [Abstract][Full Text] [Related]
18. Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal. Kotlyar M; Brauer LH; al'absi M; Adson DE; Robiner W; Thuras P; Harris J; Finocchi ME; Bronars CA; Candell S; Hatsukami DK Pharmacol Biochem Behav; 2006 Mar; 83(3):370-9. PubMed ID: 16581115 [TBL] [Abstract][Full Text] [Related]
19. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany]. Bergmann L; Warncke W; Herschel M Pneumologie; 2004 Mar; 58(3):140-6. PubMed ID: 15007784 [TBL] [Abstract][Full Text] [Related]
20. Bupropion SR for the treatment of smokeless tobacco use. Dale LC; Ebbert JO; Glover ED; Croghan IT; Schroeder DR; Severson HH; Hurt RD Drug Alcohol Depend; 2007 Sep; 90(1):56-63. PubMed ID: 17353101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]